Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and ... with idiopathic pulmonary fibrosis (IPF). Patients currently ...
Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor ... of bexotegrast in patients with idiopathic pulmonary ...
Researchers conducted a retrospective study to develop and pilot test START, a multimedia-based symptom appraisal tool for autoimmune rheumatic diseases (ARDs), which showed promising sensitivity and ...
The three phases of schizophrenia are the prodromal, active, and residual phases. Symptoms of schizophrenia can depend on the phase. Early symptoms of schizophrenia may be similar to other conditions.
removed from the lung fibrosis. There are currently no cell based therapies for ILD and in this regard the study is novel with important potential for clinical impact if validated in Phase 2 and 3 ...
However, given that this is a Phase 1 study with a small sample size, conclusions regarding efficacy should not yet be made. In idiopathic pulmonary fibrosis (IPF) patients, alveolar epithelium ...
RESEARCHERS at Vanderbilt University Medical Center, the University of Michigan Medical School, and the Translational Genomics Research Institute (TGen) have made significant strides in understanding ...
Pulmostem is under clinical development by Amniotics and currently in Phase ... respiratory distress syndrome, coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome ...
aCenter for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA ...
The role of IL-1β and TGF-β in lung repair and fibrosis in children remains unknown. Mechanisms that regulate the resolution of inflammation and repair in ARDS patients remain poorly understood ...
AROC-3 by Arrowhead Pharmaceuticals for IgA Nephropathy (Berger’s Disease): Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores ... inflammatory, idiopathic pulmonary fibrosis, idiopathic pulmonary fibrosis, much-obstructive, alpha-1 liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results